Heron Therapeutics Inc (NASDAQ:HRTX) shares, rose in value on Thursday, March 06, with the stock price down by -1.67% to the previous day’s close as strong demand from buyers drove the stock to $2.36.
Actively observing the price movement in the last trading, the stock closed the session at $2.40. Referring to stock’s 52-week performance, its high was $3.93, and the low was $1.04. On the whole, HRTX has fluctuated by 30.39% over the past month.
With the market capitalization of Heron Therapeutics Inc currently standing at about $359.50 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 158.17M, with a low estimate of 35.25M and a high estimate of 38.1M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 37.08M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HRTX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of HRTX currently trading nearly 24.11% and 34.84% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 64.20, while the 7-day volatility ratio is showing 15.24% which for the 30-day chart, stands at 8.86%. Furthermore, Heron Therapeutics Inc (HRTX)’s beta value is 1.39, and its average true range (ATR) is 0.19.
A comparison of Heron Therapeutics Inc (HRTX) with its peers suggests the former has fared considerably weaker in the market. HRTX showed an intraday change of -1.67% in last session, and over the past year, it shrunk by -7.63%%.
Data on historical trading for Heron Therapeutics Inc (NASDAQ:HRTX) indicates that the trading volumes over the past 3 months, they’ve averaged 2.01 million. According to company’s latest data on outstanding shares, there are 152.13 million shares outstanding.
Nearly 0.87% of Heron Therapeutics Inc’s shares belong to company insiders and institutional investors own 75.66% of the company’s shares. The stock has risen by 54.25% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HRTX stock heading into the next quarter.
